Canada Pension Plan Investment Board
NBIX icon

Canada Pension Plan Investment Board’s Neurocrine Biosciences NBIX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Buy
89,100
+62,300
+232% +$8.27M 0.01% 594
2025
Q4 		$3.8M Buy
+26,800
New +$3.88M ﹤0.01% 831
2025
Q3 		– Sell
-31,300
Closed -$3.93M – 1436
2025
Q2 		$3.93M Sell
31,300
-160,199
-84% -$18.4M ﹤0.01% 746
2025
Q1 		$21.2M Buy
191,499
+157,399
+462% +$19.9M 0.02% 443
2024
Q4 		$4.65M Sell
34,100
-16,700
-33% -$2.07M ﹤0.01% 727
2024
Q3 		$5.85M Sell
50,800
-15,649
-24% -$2.15M 0.01% 671
2024
Q2 		$9.15M Sell
66,449
-122,100
-65% -$16.7M 0.01% 602
2024
Q1 		$26M Buy
188,549
+122,649
+186% +$16.8M 0.03% 403
2023
Q4 		$8.68M Buy
65,900
+8,800
+15% +$1.01M 0.01% 550
2023
Q3 		$6.42M Sell
57,100
-40,932
-42% -$4.31M 0.01% 559
2023
Q2 		$9.24M Buy
98,032
+17,332
+21% +$1.69M 0.01% 484
2023
Q1 		$8.17M Buy
80,700
+16,486
+26% +$1.72M 0.01% 492
2022
Q4 		$7.67M Buy
64,214
+52,514
+449% +$6.15M 0.01% 446
2022
Q3 		$1.24M Buy
11,700
+8,300
+244% +$842K ﹤0.01% 827
2022
Q2 		$331K Sell
3,400
-500
-13% -$46.1K ﹤0.01% 1013
2022
Q1 		$366K Sell
3,900
-21,100
-84% -$1.79M ﹤0.01% 994
2021
Q4 		$2.13M Buy
+25,000
New +$2.3M ﹤0.01% 881
2021
Q2 		– Sell
-17,855
Closed -$1.74M – 1286
2021
Q1 		$1.74M Buy
17,855
+10,007
+128% +$1.05M ﹤0.01% 896
2020
Q4 		$752K Buy
7,848
+6,009
+327% +$580K ﹤0.01% 1066
2020
Q3 		$177K Sell
1,839
-16,611
-90% -$1.92M ﹤0.01% 932
2020
Q2 		$2.25M Sell
18,450
-3,275
-15% -$362K ﹤0.01% 701
2020
Q1 		$1.88M Buy
21,725
+1,056
+5% +$103K ﹤0.01% 741
2019
Q4 		$2.22M Sell
20,669
-4,831
-19% -$506K ﹤0.01% 827
2019
Q3 		$2.3M Sell
25,500
-55,031
-68% -$5.14M ﹤0.01% 819
2019
Q2 		$6.8M Buy
+80,531
New +$6.61M 0.01% 652
2017
Q4 		– Sell
-19,300
Closed -$1.18M – 1205
2017
Q3 		$1.18M Sell
19,300
-5,400
-22% -$285K ﹤0.01% 927
2017
Q2 		$1.14M Buy
24,700
+8,200
+50% +$398K ﹤0.01% 911
2017
Q1 		$714K Buy
16,500
+4,800
+41% +$206K ﹤0.01% 946
2016
Q4 		$453K Buy
11,700
+2,400
+26% +$109K ﹤0.01% 865
2016
Q3 		$471K Buy
+9,300
New +$463K ﹤0.01% 877
2016
Q2 		– Sell
-17,625
Closed -$697K – 1134
2016
Q1 		$697K Sell
17,625
-50,800
-74% -$2.02M ﹤0.01% 867
2015
Q4 		$3.87M Buy
68,425
+11,400
+20% +$579K 0.02% 586
2015
Q3 		$2.27M Buy
+57,025
New +$2.76M 0.01% 724

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Pension Plan Investment Board's NBIX Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Neurocrine Biosciences (NBIX) stake by 232% in Q1 2026, buying an estimated $8.27M and bringing the position to 89,100 shares worth $11.7M. The position accounts for 0.01% of the portfolio, ranked #594.

Canada Pension Plan Investment Board first reported a position in NBIX in Q3 2015 and has held it in 33 quarters since. The position peaked at $26M in Q1 2024. 695 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Canada Pension Plan Investment Board held 89,100 shares of Neurocrine Biosciences worth $11.7M as of Q1 2026.
  • Canada Pension Plan Investment Board bought 62,300 Neurocrine Biosciences shares in Q1 2026, an estimated $8.27M.
  • Neurocrine Biosciences made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #594 holding.
  • Canada Pension Plan Investment Board first reported a position in Neurocrine Biosciences in Q3 2015 and has held it in 33 quarters since.
  • Canada Pension Plan Investment Board's Neurocrine Biosciences position peaked at $26M in Q1 2024.
  • 695 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.